Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G




Comment for Type of Reporting Person:  This percentage figure is based upon 34,098,960 shares of Class A Common Stock outstanding, composed of: (i) 32,287,000 shares of Class A Common Stock outstanding as of November 1, 2024, as reported in the Issuer's Form 10-Q/A filed with the SEC on November 26, 2024 and (ii) 1,811,960 shares of Class A Common Stock issuable upon conversion of convertible preferred securities.


SCHEDULE 13G



 
D. E. Shaw & Co., L.P.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:02/14/2025
 
D. E. Shaw & Co., L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Authorized Signatory
Date:02/14/2025
 
D. E. Shaw Adviser, L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Chief Compliance Officer
Date:02/14/2025
 
D. E. Shaw Manager, L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Authorized Signatory
Date:02/14/2025
 
DESALKIV Portfolios, L.L.C.
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Authorized Signatory
Date:02/14/2025
 
David E. Shaw
 
Signature:/s/ Daniel R. Marcus
Name/Title:Daniel R. Marcus / Attorney-in-Fact for David E. Shaw
Date:02/14/2025

Comments accompanying signature:  Exhibit 1: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co., Inc., in favor of the signatories hereto, among others, dated August 1, 2024. Exhibit 2: Power of Attorney, granted by David E. Shaw relating to D. E. Shaw & Co. II, Inc., in favor of the signatories hereto, among others, dated August 1, 2024.
Exhibit Information

Exhibit 3: Joint Filing Agreement, by and among the Reporting Persons, dated February 14, 2025.